2024 Tandem Meetings

The 2024 Tandem Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR took place February 21-24, 2024 in San Antonio, Texas, and featured the latest scientific updates, new technologies, and innovative products in hematopoietic stem cell transplantation and cellular therapy.

Novel Duplex Sequencing Assay Improves Detection of MRD in AML

The novel DuplexSeq AML-XP next-generation sequencing assay was highly accurate for detecting MRD in AML.

What Is the Benefit of Blinatumomab in MRD-Positive B-Cell ALL?

53.8% of patients treated with blinatumomab achieved MRD negativity within a median of 3.1 months, as detected with clonoSEQ.

What Is the Best Timing for CAR-T Treatment in Patients With LBCL?

Patients with LBCL who received CAR T-cell therapy earlier in treatment had lower occurrences of severe neutropenia.

Study Identifies Key Challenges, Needs Among CAR-T Therapies for MM

The study used public data from various online sources related to approved CAR-T therapies for MM.